FDA Commissioner's India Trip Underscores Quality Theme and Regulatory Leverage
This article was originally published in RPM Report
Executive Summary
Hamburg goes to engage and educate but also to deliver a message to Indian manufacturers: FDA has more funding, human resources, and authorities than it has ever had before to regulate firms outside of the US.